Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia)

[1]  R. Timpl,et al.  Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin. , 2001, European journal of biochemistry.

[2]  R. Timpl,et al.  Perlecan Maintains the Integrity of Cartilage and Some Basement Membranes , 1999, The Journal of cell biology.

[3]  Yoshihiko Yamada,et al.  Perlecan is essential for cartilage and cephalic development , 1999, Nature Genetics.

[4]  M. Schachner,et al.  Tenascin-R Is a Functional Modulator of Sodium Channel β Subunits* , 1999, The Journal of Biological Chemistry.

[5]  H. Peng,et al.  Acetylcholinesterase Clustering at the Neuromuscular Junction Involves Perlecan and Dystroglycan , 1999, The Journal of cell biology.

[6]  L G Christova,et al.  Single motor unit activity pattern in patients with Schwartz-Jampel syndrome , 1999, Journal of neurology, neurosurgery, and psychiatry.

[7]  W. Catterall,et al.  Interaction of voltage-gated sodium channels with the extracellular matrix molecules tenascin-C and tenascin-R. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Iozzo.  Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.

[9]  B. Fontaine,et al.  Diseases caused by voltage-gated ion channels. , 1997, Molecular aspects of medicine.

[10]  T. Chowdhury,et al.  Genetic Variation of the Heparan Sulfate Proteoglycan Gene (Perlecan Gene): Association With Urinary Albumin Excretion in IDDM Patients , 1997, Diabetes.

[11]  A. Wintzen,et al.  Repetitive CMAPs: Mechanisms of neural and synaptic genesis , 1996, Muscle & nerve.

[12]  J. Weissenbach,et al.  Recessive Schwartz-Jampel syndrome (SJS): confirmation of linkage to chromosome 1p, evidence of genetic homogeneity and reduction of the SJS locus to a 3-cM interval , 1996, Human Genetics.

[13]  J. Weissenbach,et al.  Localization of the Schwartz-Jampel syndrome (SJS) locus to chromosome 1p34-p36.1 by homozygosity mapping. , 1995, Human molecular genetics.

[14]  R. Timpl,et al.  Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif. , 1995, European journal of biochemistry.

[15]  S. Ledbetter,et al.  Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. , 1995, Journal of cell science.

[16]  R. Iozzo,et al.  Structural characterization of the complete human perlecan gene and its promoter. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. R. Dodge,et al.  Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. , 1992, The Journal of biological chemistry.

[18]  K. Tryggvason,et al.  Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor , 1992, The Journal of cell biology.

[19]  P. Beighton,et al.  Schwartz-Jampel syndrome (chondrodystrophic myotonia). , 1992, Journal of medical genetics.

[20]  A. Ljubimov,et al.  Mammalian tissue distribution of a large heparan sulfate proteoglycan detected by monoclonal antibodies. , 1989, Matrix.

[21]  Marvin B. Shapiro,et al.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.

[22]  S. Rennard,et al.  Isolation of a heparan sulfate-containing proteoglycan from basement membrane. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Cao,et al.  Schwartz-Jampel syndrome Clinical, electrophysiological and histopathological study of a severe variant , 1978, Journal of the Neurological Sciences.

[24]  L. Hinterbuchner,et al.  Myotonia, dwarfism, diffuse bone disease and unusual ocular and facial abnormalities (a new syndrome). , 1965, Brain : a journal of neurology.

[25]  D. Moerman,et al.  Mutations in the unc-52 gene responsible for body wall muscle defects in adult Caenorhabditis elegans are located in alternatively spliced exons. , 1995, Genetics.

[26]  D. Noonan,et al.  Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. , 1993, Kidney international.

[27]  M. Ben Hamida,et al.  [Schwartz-Jampel syndrome. Clinical and histopathological study of 4 cases]. , 1991, Revue neurologique.

[28]  P. Baldet,et al.  E.M.G. studies of two family cases of the Schwartz and Jampel syndrome (osteo-chondro-muscular dystrophy with myotonia). , 1975, Electromyography and clinical neurophysiology.